These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24304495)

  • 1. Allospecific rejection of MHC class I-deficient bone marrow by CD8 T cells.
    Haspot F; Li HW; Lucas CL; Fehr T; Beyaz S; Sykes M
    Am J Transplant; 2014 Jan; 14(1):49-58. PubMed ID: 24304495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid deletional peripheral CD8 T cell tolerance induced by allogeneic bone marrow: role of donor class II MHC and B cells.
    Fehr T; Wang S; Haspot F; Kurtz J; Blaha P; Hogan T; Chittenden M; Wekerle T; Sykes M
    J Immunol; 2008 Sep; 181(6):4371-80. PubMed ID: 18768896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway.
    Ito H; Kurtz J; Shaffer J; Sykes M
    J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: potential role of a veto mechanism.
    Martin PJ
    Blood; 1996 Aug; 88(3):962-9. PubMed ID: 8704255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.
    Hayashi H; LeGuern C; Sachs DH; Sykes M
    Bone Marrow Transplant; 1996 Aug; 18(2):285-92. PubMed ID: 8864436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synthetic CD4-CDR3 peptide analog enhances bone marrow engraftment across major histocompatibility barriers.
    Koch U; Korngold R
    Blood; 1997 Apr; 89(8):2880-90. PubMed ID: 9108408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactive CD8 T cell tolerance requires recipient B cells, dendritic cells, and MHC class II.
    Fehr T; Haspot F; Mollov J; Chittenden M; Hogan T; Sykes M
    J Immunol; 2008 Jul; 181(1):165-73. PubMed ID: 18566381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recipient dendritic cells, but not B cells, are required antigen-presenting cells for peripheral alloreactive CD8+ T-cell tolerance.
    Mollov JL; Lucas CL; Haspot F; Gaspar JKC; Guzman A; Sykes M
    Am J Transplant; 2010 Mar; 10(3):518-526. PubMed ID: 20121730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of hemopoietic chimerism and allograft tolerance after allogeneic bone marrow transplantation.
    Umemura A; Morita H; Li XC; Tahan S; Monaco AP; Maki T
    J Immunol; 2001 Sep; 167(6):3043-8. PubMed ID: 11544287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nature of tolerance in adult recipient mice made tolerant of alloantigens with supralethal irradiation followed by syngeneic bone marrow cell transplantation plus injection of F1 spleen cells.
    Tomita Y; Himeno K; Mayumi H; Tokuda N; Nomoto K
    Transplantation; 1989 Jun; 47(6):1021-9. PubMed ID: 2660340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.
    Fehr T; Takeuchi Y; Kurtz J; Wekerle T; Sykes M
    Eur J Immunol; 2005 Sep; 35(9):2679-90. PubMed ID: 16082727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8(+), alphabeta-TCR(+), and gammadelta-TCR(+) cells in the recipient hematopoietic environment mediate resistance to engraftment of allogeneic donor bone marrow.
    Xu H; Exner BG; Cramer DE; Tanner MK; Mueller YM; Ildstad ST
    J Immunol; 2002 Feb; 168(4):1636-43. PubMed ID: 11823491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen.
    Manilay JO; Pearson DA; Sergio JJ; Swenson KG; Sykes M
    Transplantation; 1998 Jul; 66(1):96-102. PubMed ID: 9679828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice.
    Vallera DA; Taylor PA; Sprent J; Blazar BR
    Transplantation; 1994 Jan; 57(2):249-56. PubMed ID: 7906058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y; Sachs DH; Khan A; Sykes M
    Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance.
    Kurtz J; Raval F; Vallot C; Der J; Sykes M
    Blood; 2009 Apr; 113(15):3475-84. PubMed ID: 19179471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance.
    He KM; Ma Y; Wang S; Min WP; Zhong R; Jevnikar A; Zhang ZX
    Eur J Immunol; 2007 Dec; 37(12):3455-66. PubMed ID: 18000953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation.
    Kraus AB; Shaffer J; Toh HC; Preffer F; Dombkowski D; Saidman S; Colby C; George R; McAfee S; Sackstein R; Dey B; Spitzer TR; Sykes M
    Exp Hematol; 2003 Jul; 31(7):609-21. PubMed ID: 12842706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.